Skip to main content
Top

Current Oncology Reports

Issue 1/2012

Content (13 Articles)

Breast Cancer (KR Fox, Section Editor)

Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?

Alberto J. Montero, Mauricio Escobar, Gilberto Lopes, Stefan Glück, Charles Vogel

Breast Cancer (KR Fox, Section Editor)

Hypofractionated Radiation Therapy in the Treatment of Early-Stage Breast Cancer

Gary M. Freedman

Breast Cancer (KR Fox, Section Editor)

Whither the PET Scan? The Role of PET Imaging in the Staging and Treatment of Breast Cancer

Alessandra Gennari, Arnoldo Piccardo, Vania Altrinetti, Davide Corradengo, Giampiero Villavecchia, Andrea De Censi

Breast Cancer (KR Fox, Section Editor)

Neoadjuvant Clinical Trials for the Treatment of Primary Breast Cancer: The Experience of the German Study Groups

Michael Untch, Sibylle Loibl, Gottfried E. Konecny, Gunter von Minckwitz

Breast Cancer (KR Fox, Section Editor)

The Role of Lapatinib in the Preoperative Therapy of Breast Cancer

Rebecca L. Hirsh, Angela DeMichele

Neuro-oncology (M Gilbert, Section Editor)

Epidemiology of Brain Metastases

Lakshmi Nayak, Eudocia Quant Lee, Patrick Y. Wen

Neuro-oncology (M Gilbert, Section Editor)

Radiation Therapy in the Prevention of Brain Metastases

Joseph A. Bovi, Julia White

Neuro-oncology (M Gilbert, Section Editor)

Chemoprevention for Brain Metastases

Van A. Trinh, Wen-Jen Hwu

Neuro-oncology (M Gilbert, Section Editor)

Management of Brain Metastasis: Past Lessons, Modern Management, and Future Considerations

Eugene Koay, Erik P. Sulman

Neuro-oncology (M Gilbert, Section Editor)

Treatment of Brain Metastases: Chemotherapy

Sean A. Grimm

Neuro-oncology (M Gilbert, Section Editor)

Clinical Trial Design in Brain Metastasis: Approaches for a Unique Patient Population

David M. Peereboom

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine